Werewolf Therapeutics, Inc.
NASDAQ:HOWL
2.22 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||
Current Assets: | ||||||||||||||||
Cash & Cash Equivalents
| 135.303 | 139.189 | 134.343 | 130.058 | 137.452 | 147.868 | 129.315 | 140.45 | 145.712 | 143.711 | 157.531 | 170.438 | 183.233 | 84.602 | 92.57 | -17.896 |
Short Term Investments
| 0 | 268.686 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35.792 |
Cash and Short Term Investments
| 135.303 | 139.189 | 134.343 | 130.058 | 137.452 | 147.868 | 129.315 | 140.45 | 145.712 | 143.711 | 157.531 | 170.438 | 183.233 | 84.602 | 92.57 | 17.896 |
Net Receivables
| 0.545 | 0.775 | 1.35 | 5.911 | 6.927 | 6.255 | 6.928 | 4.3 | 2.22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | -8.99 | 0.208 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 2.94 | 2.32 | 2.677 | 3.079 | 2.812 | 2.439 | 3.957 | 6.837 | 6.233 | 1.725 | 3.537 | 3.966 | 3.126 | 0.263 | 0.344 | 0 |
Total Current Assets
| 138.788 | 142.284 | 138.37 | 130.058 | 147.399 | 156.562 | 140.2 | 151.587 | 154.165 | 145.436 | 161.068 | 174.404 | 186.359 | 84.865 | 92.914 | 17.896 |
Non-Current Assets: | ||||||||||||||||
Property, Plant & Equipment, Net
| 13.439 | 14.041 | 14.846 | 15.593 | 16.169 | 16.826 | 17.451 | 17.773 | 18.101 | 17.345 | 16.325 | 2.752 | 2.824 | 2.999 | 3.122 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 1.211 | 21.027 | 21.023 | 21.019 | 21.015 | 21.011 | 1.214 | 1.211 | 1.208 | 1.208 | 1.208 | 1.208 | 1.208 | 0.298 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.265 | 0.248 | 0.594 | 0.516 | 0.652 | 0.67 | 1.38 | 1.853 | 1.855 | 0.642 | 0.649 | 0.011 | 0.027 | 1.274 | 0.362 | -17.896 |
Total Non-Current Assets
| 14.915 | 35.316 | 36.463 | 37.128 | 37.836 | 38.507 | 20.045 | 20.837 | 21.164 | 19.195 | 18.182 | 3.971 | 4.059 | 4.571 | 3.484 | -17.896 |
Total Assets
| 153.703 | 177.6 | 174.833 | 176.386 | 185.235 | 195.069 | 160.245 | 172.424 | 175.329 | 164.631 | 179.25 | 178.375 | 190.418 | 89.436 | 96.398 | 0 |
Liabilities & Equity: | ||||||||||||||||
Current Liabilities: | ||||||||||||||||
Account Payables
| 1.467 | 1.594 | 1.336 | 1.386 | 1.49 | 2.106 | 1.221 | 1.388 | 2.59 | 1.381 | 2.037 | 1.457 | 3.193 | 1.8 | 1.021 | 0 |
Short Term Debt
| 1.274 | 12.903 | 8.275 | 3.272 | 1.97 | 2.146 | 2.084 | 2.02 | 1.871 | 1.458 | 1.072 | 0.744 | 0.721 | 0.699 | 0.677 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0.502 | 0.907 | 2.402 | 1.606 | 5.317 | 6.532 | 10.458 | 11.817 | 0 | 0 | 0 | 0 | 2.89 | 0 | 0 |
Other Current Liabilities
| 8.701 | 6.215 | 8.86 | -4.658 | 9.94 | 12.153 | 14.152 | 13.934 | 14.09 | 8.189 | 8.765 | 5.574 | 3.456 | 0.02 | 3.586 | 0 |
Total Current Liabilities
| 11.442 | 21.214 | 19.378 | 2.402 | 15.006 | 21.722 | 23.989 | 27.8 | 30.368 | 11.028 | 11.874 | 7.775 | 7.37 | 5.409 | 5.284 | 0 |
Non-Current Liabilities: | ||||||||||||||||
Long Term Debt
| 25.163 | 27.748 | 32.656 | 37.564 | 50.847 | 51.106 | 12.6 | 13.143 | 13.675 | 14.285 | 14.589 | 1.297 | 1.492 | 1.683 | 1.864 | 0 |
Deferred Revenue Non-Current
| 0 | 0.431 | 0.433 | 0.588 | 0.783 | 1.168 | 1.128 | 0.343 | 1.254 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 10.189 | 10.559 | 10.764 | -0.783 | -1.168 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 13.08 | 0.431 | 0.433 | 0.588 | 0.783 | 1.168 | 0.191 | 0.191 | 0.191 | 0 | 0 | 0 | 0 | 236.098 | 141.113 | 0 |
Total Non-Current Liabilities
| 38.243 | 38.799 | 44.081 | 49.504 | 51.63 | 52.274 | 13.919 | 13.677 | 15.12 | 14.285 | 14.589 | 1.297 | 1.492 | 237.781 | 142.977 | 0 |
Total Liabilities
| 49.685 | 60.013 | 63.459 | 2.402 | 66.636 | 73.996 | 37.908 | 41.477 | 45.488 | 25.313 | 26.463 | 9.072 | 8.862 | 243.19 | 148.261 | 0 |
Equity: | ||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 178.375 | 190.418 | 118.765 | 141.082 | 34.073 |
Common Stock
| 0.004 | 0.004 | 0.004 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0 |
Retained Earnings
| -377.515 | -360.266 | -344.073 | -332.07 | -323.785 | -318.687 | -306.705 | -294.775 | -282.832 | -268.238 | -252.895 | -235.026 | -221.268 | -153.756 | -51.865 | 0 |
Accumulated Other Comprehensive Income/Loss
| 0 | 111.374 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -178.375 | -190.418 | -354.863 | 0 | -24.304 |
Other Total Stockholders Equity
| 481.529 | 366.475 | 455.443 | 444.51 | 442.381 | 439.757 | 429.039 | 425.719 | 412.671 | 407.554 | 405.68 | 404.327 | 402.822 | 236.098 | -141.082 | 0 |
Total Shareholders Equity
| 104.018 | 117.587 | 111.374 | 112.443 | 118.599 | 121.073 | 122.337 | 130.947 | 129.841 | 139.318 | 152.787 | 169.303 | 181.556 | -153.754 | -51.863 | 9.769 |
Total Equity
| 104.018 | 117.587 | 111.374 | 112.443 | 118.599 | 121.073 | 122.337 | 130.947 | 129.841 | 139.318 | 152.787 | 169.303 | 181.556 | -153.754 | -51.863 | 9.769 |
Total Liabilities & Shareholders Equity
| 153.703 | 177.6 | 174.833 | 176.386 | 185.235 | 195.069 | 160.245 | 172.424 | 175.329 | 164.631 | 179.25 | 178.375 | 190.418 | 89.436 | 96.398 | 9.769 |